Novel Therapies Expand Hypogonadism Treatment Options

摘要

Management of hypogonadism with testosterone replacement therapy is complex, with a variety of disease state, medication, and monitoring considerations. Testosterone replacement traditionally has been available as transdermal and injection therapies and as subdermal pellets. New modalities of therapy recently approved include a testosterone nasal gel, an autoinjectable, and an oral capsule. Pharmacists should have a thorough knowledge of all testosterone replacement therapies to counsel patients and make recommendations regarding efficacy and potential adverse effects to optimize and individualize therapy for hypogonadism.